HA
BNTX icon

Harbor Advisors’s BioNTech BNTX Stock Holding History

Harbor Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$213K – 191
2025
Q2 		$213K Buy
+2,000
New +$202K 0.03% 174
2025
Q1 		– Sell
-2,000
Closed -$228K – 194
2024
Q4 		$228K Hold
2,000
– – 0.04% 174
2024
Q3 		$238K Buy
+2,000
New +$184K 0.04% 161
2024
Q1 		– Sell
-2,000
Closed -$211K – 179
2023
Q4 		$211K Hold
2,000
– – 0.04% 158
2023
Q3 		$217K Buy
+2,000
New +$221K 0.05% 139

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Harbor Advisors's BNTX Position: Q3 2025 in Review

Harbor Advisors sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 2,000 shares — an estimated $213K sold.

Harbor Advisors first reported a position in BNTX in Q3 2023 and held it in 5 quarters. The position peaked at $238K in Q3 2024. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Harbor Advisors reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Harbor Advisors sold 2,000 BioNTech shares in Q3 2025, an estimated $213K.
  • Harbor Advisors first reported a position in BioNTech in Q3 2023 and held it in 5 quarters.
  • Harbor Advisors's BioNTech position peaked at $238K in Q3 2024.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Harbor Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.